DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
-1.96%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$114M
AUM Growth
+$114M
(-21%)
Cap. Flow
-$23.8M
Cap. Flow
% of AUM
-20.92%
Top 10 Holdings %
Top 10 Hldgs %
42.25%
Holding
85
New
11
Increased
13
Reduced
18
Closed
19
Top Buys
1 |
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
|
$4.1M |
2 |
iShares Biotechnology ETF
IBB
|
$2.31M |
3 |
BPMC
Blueprint Medicines
BPMC
|
$2.03M |
4 |
Cidara Therapeutics
CDTX
|
$1.66M |
5 |
ADXS
Advaxis, Inc.
ADXS
|
$1.25M |
Top Sells
Sector Composition
1 | Healthcare | 81.51% |